These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9090357)

  • 1. Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline.
    Dodt JE; Byerly MJ; Cuadros C; Christensen RC
    Am J Psychiatry; 1997 Apr; 154(4):582. PubMed ID: 9090357
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.
    Allen L; Tejera C
    Am J Psychiatry; 1994 Jul; 151(7):1096-7. PubMed ID: 8010373
    [No Abstract]   [Full Text] [Related]  

  • 3. Medication optimization during clozapine treatment.
    Suppes T; Rush AJ
    J Clin Psychiatry; 1996 Jul; 57(7):307-8. PubMed ID: 8666574
    [No Abstract]   [Full Text] [Related]  

  • 4. Sertraline and mental retardation with obsessive-compulsive disorder.
    Wiener K; Lamberti JS
    Am J Psychiatry; 1993 Aug; 150(8):1270. PubMed ID: 8328577
    [No Abstract]   [Full Text] [Related]  

  • 5. Panic attacks precipitated by sertraline.
    Zinner SH
    Am J Psychiatry; 1994 Jan; 151(1):147-8. PubMed ID: 8267115
    [No Abstract]   [Full Text] [Related]  

  • 6. Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
    Koran LM; Mueller K; Maloney A
    J Clin Psychopharmacol; 1996 Jun; 16(3):253-4. PubMed ID: 8784659
    [No Abstract]   [Full Text] [Related]  

  • 7. Obsessive-compulsive symptoms in schizophrenia induced by risperidone and responding to fluoxetine.
    Levy E; Margolese HC; Sultan S; Chouinard G
    Can J Psychiatry; 2003 Nov; 48(10):709-10. PubMed ID: 14674056
    [No Abstract]   [Full Text] [Related]  

  • 8. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
    Chouinard G
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():37-41. PubMed ID: 1484177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW; Morton WA; Lydiard RB
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Response to sertraline in adolescents with obsessive-compulsive disorder].
    Rodríguez-Ramos P; Mardomingo Sanz MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):17-21. PubMed ID: 9549132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
    Greist JH; Jefferson JW; Kobak KA; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowtiz MR; Lydiard B
    Int Clin Psychopharmacol; 1995 Jun; 10(2):57-65. PubMed ID: 7673657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
    Murdoch D; McTavish D
    Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability to cry during SRI treatment.
    Oleshansky MA; Labbate LA
    J Clin Psychiatry; 1996 Dec; 57(12):593. PubMed ID: 9010124
    [No Abstract]   [Full Text] [Related]  

  • 15. Sertraline in the treatment of neurotic excoriations and related disorders.
    Kalivas J; Kalivas L; Gilman D; Hayden CT
    Arch Dermatol; 1996 May; 132(5):589-90. PubMed ID: 8624163
    [No Abstract]   [Full Text] [Related]  

  • 16. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
    Rasmussen S; Hackett E; DuBoff E; Greist J; Halaris A; Koran LM; Liebowitz M; Lydiard RB; McElroy S; Mendels J; O'Connor K
    Int Clin Psychopharmacol; 1997 Nov; 12(6):309-16. PubMed ID: 9547132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High doses of sertraline for treatment-resistant obsessive-compulsive disorder.
    Byerly MJ; Goodman WK; Christensen R
    Am J Psychiatry; 1996 Sep; 153(9):1232-3. PubMed ID: 8780435
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonin reuptake blockers for the treatment of obsessional jealousy.
    Stein DJ; Hollander E; Josephson SC
    J Clin Psychiatry; 1994 Jan; 55(1):30-3. PubMed ID: 8294389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of risperidone-induced obsessive-compulsive symptoms.
    Alzaid K; Jones BD
    J Clin Psychopharmacol; 1997 Feb; 17(1):58-9. PubMed ID: 9004062
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential response of psychotic and obsessive symptoms to risperidone in an adolescent.
    Dryden-Edwards RC; Reiss AL
    J Child Adolesc Psychopharmacol; 1996; 6(2):139-45. PubMed ID: 9231306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.